Temozolomide (TMZ) in the Treatment of Glioblastoma Multiforme—A Literature Review and Clinical Outcomes

Glioblastoma multiforme (GBM) is one of the most aggressive primary tumors of the central nervous system. It is associated with a very poor prognosis, with up to half of patients failing to survive the first year after diagnosis. It develops from glial tissue and belongs to the adult-type diffuse gl...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Marcin Jezierzański, Natalia Nafalska, Małgorzata Stopyra, Tomasz Furgoł, Michał Miciak, Jacek Kabut, Iwona Gisterek-Grocholska
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2024-07-01
Colecção:	Current Oncology
Assuntos:	temozolomide: glioblastoma multiforme anticancer therapy effectiveness overall survival
Acesso em linha:	https://www.mdpi.com/1718-7729/31/7/296
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!